In a recent Federal Bar Association breakfast briefing hosted by Eversheds Sutherland, officials from the Internal Revenue Service (IRS) and Department of the Treasury (Treasury) gave insights into the newly issued substantive guidance related to the treatment of specified research and experimental (SRE) expenditures under Section 174, as documented in Notice 2023-63 (Notice).
The discussion came as a wake-up call for legal experts and corporate law firms alike, signaling important changes and clarifications concerning the expenditures of companies focused on research and experimental advances, operations that are critical to the innovation-driven economy.
This recent guidance from the IRS and the Treasury, as encapsulated in Notice 2023-63, has added new dimensions to understanding Section 174 of the Internal Revenue Code of 1986, dealing with research and experimental expenditures. As per the issued Notice, certain expenditures that are categorized as either research or experimental come under the purview of the tax law statute and should be treated accordingly.
The insightful discussion at the Federal Bar Association’s breakfast briefing provided attendees with a deeper understanding of the guidance, helping to untangle the complexities of the IRS’s approach to R&E expenditures. Moreover, shared perspectives from officials of the IRS and Department of the Treasury serve as valuable information for corporations and law firms to shape their tax planning strategies and provide accurate advice to their clients.
The details and further implications of Notice 2023-63 are set to be further dissected and discussed within the legal fraternity, promising a wide-reaching impact on businesses focusing on research and development ventures. As these discussions progress, legal practitioners and corporations will certainly look forward to more such enlightening sessions from the IRS and Treasury.